?? Excited to announce that Ella from Hyperchem will be attending the CMC -CHINA Conference on August 15-16, focusing on groundbreaking discussions around GLP-1 and its future in peptide therapy! ??
Here's a sneak peek into the sessions that will shape the conversation:
- 09:00-09:25: The Variability of CMC Research in Clinical Trials of Peptide Drugs
- 09:25-09:50: Trends in GLP-RAS New Drug Development: Long-acting and Multi-target
- 09:50-10:15: Discovery and Clinical Translation of Novel GLP-1R/GIPR Dual-target Agonists
- 10:15-10:40: iCVETide Peptide Drug Discovery Platform Technology and Practical Case Sharing
- 10:40-11:05: Quality Control Strategies for Peptide Drugs
- 11:05-11:30: Progress and Commercial Prospects of GLP Drugs
- 11:30-11:55: Differentiated Development Strategy for GLP-1 Drugs
- 11:55-12:20: Roundtable Discussion: Expanding the Field of Peptide Therapy and Overseas Opportunities
- 13:30-13:55: GLP-1, Besides Weight Loss, What Else Can It Offer?
- 13:55-14:20: Case Study on the Identification of Impurities in Semaglutide and Tirzepatide
- 14:20-14:45: Innovative Development of Next-Generation Human Ultra-Long-Acting GLP-1 Drugs and Key Clinical Data Interpretation
- 14:45-15:10: Case Studies of High-Throughput Screening Based on a 2.4 Million Peptide Molecular Library and Peptide Chip Screening Projects
- 15:10-15:35: Epiwotide: A Broad-Spectrum Anti-Inflammatory Original Drug Alternative to Glucocorticoids
- 15:35-16:00: EMPHASES Peptide Synthesis Technology and Its Application in Drug Peptide Synthesis
- 16:00-16:25: Discovery of Cyclopeptide Innovative Drugs: From Long-Acting Echinocandins to Oral PCSK9 Inhibitors
?? Join Ella and other industry leaders as they dive deep into the latest trends and future opportunities in the field. This is a chance to stay ahead of the curve and connect with pioneers who are shaping the future of peptide drugs.
?? Interested in the future of GLP-1 and peptide therapies? Connect with Ella and let's discuss how we can innovate together!
#GLP1 #PeptideTherapy #PharmaceuticalResearch #CMConference #Innovation #DrugDevelopment #Hyperchem #ClinicalTrials
